C

Cipla Ltd

PharmaceuticalsLargecap

About the company

Cipla Limited is a pharmaceutical company. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology & cosmetology, diabetes, HIV/AIDS, infectious diseases & critical care, malaria etc.

Performance

Stock
Loading Stock value

Analyst Ratings and Key Metrics

Based on 35 analysts offering recommendations for Cipla Ltd

63%

Buy

26%

Hold

11%

Sell

Key MetricsThis StockCategory (Avg)
PE Ratio29.4441.68
PB Ratio3.656.34
Dividend Yield0.92%0.45%

Understand what these metrics mean. 

Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions